KLF2通过准PI3K/AKT介导的MMP-2/9信号传导来抑制 keloid 的进展
Dan Yu1, AoLin Zhao2, ZhiGuo Wang2
1Department of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan City, 442000 Hubei Province China.
Cytotechnology
|December 26, 2025
概括
克鲁佩尔样因子2 (KLF2) 抑制了 keloid 纤维细胞的增殖和迁移. 通过针对PI3K/AKT通路,对KLF2进行升级可能为 keloid 疾病提供新的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 状体疾病 (KD) 的特征是过度的纤维细胞增殖,迁移和入侵.
- 克鲁佩尔样因子2 (KLF2) 在 keloids 和高性痕的发病过程中的作用尚未完全理解.
研究的目的:
- 为了研究Keloid纤维细胞 (KFs) 和高性痕纤维细胞 (HSFs) 中KLF2的抗扩散,抗入侵和抗迁移活动.
- 阐明KLF2在 keloid 病原发生过程中的作用所涉及的分子通路.
主要方法:
- 在正常皮肤,皮质细胞和过度缩的痕组织和细胞系中使用西斑和qRT-PCR量化KLF2表达.
- 纤维细胞增殖,迁移和入侵的评估.
- 西部斑点分析以确定关键通路蛋白质.
主要成果:
- 与正常皮肤相比,KLF2表达在 keloid 和高性痕组织中明显较低.
- 过度表达KLF2抑制了KF和HSF的扩散,迁移和入侵.
- KLF2过度表达下调了KF中的MMP-2,MMP-9,PI3K和p-Akt,以及HSF中的PI3K/AKT通路蛋白.
结论:
- KLF2通过PI3K/AKT通路向下调节MMP-2/9,从而抑制 keloid 纤维细胞的增殖和迁移.
- KLF2代表了潜在的治疗状腺疾病的目标.
- 这些发现提供了对KLF2的功能和分子机制在 keloid 病原发生的新见解,建议新的临床治疗策略.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K


